Cargando…

The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism

OBJECTIVES: To analyze conventional ultrasound (CUS) and contrast-enhanced ultrasound (CEUS) features in patients with secondary hyperparathyroidism (SHPT) and to evaluate the clinical-ultrasonographic feature based model for predicting the severity of SHPT. METHODS: From February 2016 to March 2021...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoer, Xu, Wenxin, Huang, Tongyi, Huang, Jingzhi, Zhang, Chunyang, Zhang, Yutong, Xie, Xiaoyan, Xu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856024/
https://www.ncbi.nlm.nih.gov/pubmed/35164637
http://dx.doi.org/10.1080/0886022X.2022.2027784
_version_ 1784653753467535360
author Zhang, Xiaoer
Xu, Wenxin
Huang, Tongyi
Huang, Jingzhi
Zhang, Chunyang
Zhang, Yutong
Xie, Xiaoyan
Xu, Ming
author_facet Zhang, Xiaoer
Xu, Wenxin
Huang, Tongyi
Huang, Jingzhi
Zhang, Chunyang
Zhang, Yutong
Xie, Xiaoyan
Xu, Ming
author_sort Zhang, Xiaoer
collection PubMed
description OBJECTIVES: To analyze conventional ultrasound (CUS) and contrast-enhanced ultrasound (CEUS) features in patients with secondary hyperparathyroidism (SHPT) and to evaluate the clinical-ultrasonographic feature based model for predicting the severity of SHPT. METHODS: From February 2016 to March 2021, a total of 59 patients (age 51.3 ± 11.7 years, seCr 797.8 ± 431.7 μmol/L, iPTH 1535.1 ± 1063.9 ng/L) with SHPT (including 181 parathyroid glands (PTGs)) without the history of intact parathyroid hormone (iPTH)-reducing drugs using were enrolled. The patients were divided into the mild SHPT group (mSHPT, iPTH <800 ng/L) and the severe SHPT group (sSHPT, iPTH ≥ 800 ng/L) according to the serum iPTH level. The clinical test data of patients were collected and CUS and CEUS examinations were performed for every patient. Multivariable logistic regression model according to clinical-ultrasonographic features was adopted to establish a nomogram. We performed K-fold cross-validation on this nomogram model and nomogram performance was determined by its discrimination, calibration, and clinical usefulness. RESULTS: There were 19 patients in the mSHPT group and 40 patients in the sSHPT group. Multivariable logistic regression indicated serum calcium, serum phosphorus and total volume of PTGs were independent predictors related with serum iPTH level. Even though CEUS score of wash-in and wash-out were showed related to severity of SHPT in univariate logistic regression analysis, they were not predictors of SHPT severity (p = 0.539, 0.474 respectively). The nomogram developed by clinical and ultrasonographic features showed good calibration and discrimination. The accuracy and the area under the curve (AUC), positive predictive value (PPV), negative predictive value (NPV) and accuracy of this model were 0.888, 92.5%, 63.2% and 83.1%, respectively. When applied to internal validation, the score revealed good discrimination with stratified fivefold cross-validation in the cohort (mean AUC = 0.833). CONCLUSIONS: The clinical-ultrasonographic features model has good performance for predicting the severity of SHPT.
format Online
Article
Text
id pubmed-8856024
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88560242022-02-19 The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism Zhang, Xiaoer Xu, Wenxin Huang, Tongyi Huang, Jingzhi Zhang, Chunyang Zhang, Yutong Xie, Xiaoyan Xu, Ming Ren Fail Research Article OBJECTIVES: To analyze conventional ultrasound (CUS) and contrast-enhanced ultrasound (CEUS) features in patients with secondary hyperparathyroidism (SHPT) and to evaluate the clinical-ultrasonographic feature based model for predicting the severity of SHPT. METHODS: From February 2016 to March 2021, a total of 59 patients (age 51.3 ± 11.7 years, seCr 797.8 ± 431.7 μmol/L, iPTH 1535.1 ± 1063.9 ng/L) with SHPT (including 181 parathyroid glands (PTGs)) without the history of intact parathyroid hormone (iPTH)-reducing drugs using were enrolled. The patients were divided into the mild SHPT group (mSHPT, iPTH <800 ng/L) and the severe SHPT group (sSHPT, iPTH ≥ 800 ng/L) according to the serum iPTH level. The clinical test data of patients were collected and CUS and CEUS examinations were performed for every patient. Multivariable logistic regression model according to clinical-ultrasonographic features was adopted to establish a nomogram. We performed K-fold cross-validation on this nomogram model and nomogram performance was determined by its discrimination, calibration, and clinical usefulness. RESULTS: There were 19 patients in the mSHPT group and 40 patients in the sSHPT group. Multivariable logistic regression indicated serum calcium, serum phosphorus and total volume of PTGs were independent predictors related with serum iPTH level. Even though CEUS score of wash-in and wash-out were showed related to severity of SHPT in univariate logistic regression analysis, they were not predictors of SHPT severity (p = 0.539, 0.474 respectively). The nomogram developed by clinical and ultrasonographic features showed good calibration and discrimination. The accuracy and the area under the curve (AUC), positive predictive value (PPV), negative predictive value (NPV) and accuracy of this model were 0.888, 92.5%, 63.2% and 83.1%, respectively. When applied to internal validation, the score revealed good discrimination with stratified fivefold cross-validation in the cohort (mean AUC = 0.833). CONCLUSIONS: The clinical-ultrasonographic features model has good performance for predicting the severity of SHPT. Taylor & Francis 2022-02-15 /pmc/articles/PMC8856024/ /pubmed/35164637 http://dx.doi.org/10.1080/0886022X.2022.2027784 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhang, Xiaoer
Xu, Wenxin
Huang, Tongyi
Huang, Jingzhi
Zhang, Chunyang
Zhang, Yutong
Xie, Xiaoyan
Xu, Ming
The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism
title The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism
title_full The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism
title_fullStr The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism
title_full_unstemmed The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism
title_short The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism
title_sort value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856024/
https://www.ncbi.nlm.nih.gov/pubmed/35164637
http://dx.doi.org/10.1080/0886022X.2022.2027784
work_keys_str_mv AT zhangxiaoer thevalueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT xuwenxin thevalueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT huangtongyi thevalueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT huangjingzhi thevalueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT zhangchunyang thevalueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT zhangyutong thevalueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT xiexiaoyan thevalueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT xuming thevalueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT zhangxiaoer valueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT xuwenxin valueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT huangtongyi valueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT huangjingzhi valueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT zhangchunyang valueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT zhangyutong valueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT xiexiaoyan valueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism
AT xuming valueofclinicalultrasonographicfeaturemodeltopredicttheseverityofsecondaryhyperparathyroidism